Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:2-3

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heistad, D. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Heistad, D. D.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:2.)
© 2002 American Heart Association, Inc.


Editorials

Arteriosclerosis, Thrombosis, and Vascular Biology, 2002

Donald D. Heistad, Editor-in-Chief for the Editors
We write to provide a progress report for Arteriosclerosis, Thrombosis, and Vascular Biololgy, to provide data about some important trends and to thank several groups of people for their continued help. The goals of the Journal remain unchanged: to publish high-quality papers, provide timely review and publication, and publish papers that are of special interest to our readers.

Publication of High-Quality Papers

One key criterion for publication is the scientific validity of the conclusions, as evaluated by expert reviewers, the Editorial Board, and the Editors. A second criterion, which is more subjective, is the evaluation of the novelty and likely importance of papers. In decisions about scientific validity and importance (or priority), the Editors rely heavily on the advice of expert reviewers.

Nevertheless, assessment of the importance and quality of papers that are published is challenging. One benchmark is the impact factor. The latest available data (for 2000) indicate that the impact factor of ATVB and other journals that focus on atherosclerosis, thrombosis, and vascular biology has fluctuated during the past five years but, in general, has remained relatively constant (Figure 1). These data do not reflect the long-term, gradual increase in impact factor of ATVB during the past two decades. Compared with other journals in this area of research, it is clear that ATVB is an appropriate forum to publish excellent papers in the area.


Figure Removed (Available Only in the Full Text)
View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. Impact factor for ATVB, Thrombosis and Haemostasis (T&H), Journal of Lipid Research (JLR), Atherosclerosis, and American Journal of Physiology: Heart and . . . [Full Text of this Article]